Insmed Inc [NASDAQ: INSM] closed the trading session at $77.03.
The stocks have a year to date performance of 148.56 percent and weekly performance of 24.24 percent. The stock has been moved at 164.62 percent over the last six months. The stock has performed 28.60 percent around the most recent 30 days and changed 171.33 percent over the most recent 3-months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
If compared to the average trading volume of 3.58M shares, INSM reached to a volume of 3687165 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Insmed Inc [INSM]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for INSM shares is $81.06 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on INSM stock is a recommendation set at 1.06. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Truist have made an estimate for Insmed Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on April 23, 2024. While these analysts kept the previous recommendation, Wolfe Research raised their target price to Outperform. The new note on the price target was released on February 15, 2024, representing the official price target for Insmed Inc stock. Previously, the target price had yet another raise to $55, while Wells Fargo analysts kept a Overweight rating on INSM stock.
The Average True Range (ATR) for Insmed Inc is set at 3.34, with the Price to Sales ratio for INSM stock in the period of the last 12 months amounting to 39.37.
INSM stock trade performance evaluation
Insmed Inc [INSM] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 24.24. With this latest performance, INSM shares gained by 28.60% in over the last four-week period, additionally plugging by 164.62% over the last 6 months – not to mention a rise of 284.77% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for INSM stock in for the last two-week period is set at 78.10, with the RSI for the last a single of trading hit 79.21, and the three-weeks RSI is set at 77.73 for Insmed Inc [INSM]. The present Moving Average for the last 50 days of trading for this stock 48.85, while it was recorded at 72.09 for the last single week of trading, and 32.33 for the last 200 days.
Insmed Inc [INSM]: An insightful look at the core fundamentals
Insmed Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.61 and a Current Ratio set at 1.80.
Insmed Inc [INSM]: Institutional Ownership
The top three institutional holders of INSM stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.5034%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $178.43 billion in INSM stocks shares; and BERKSHIRE HATHAWAY INC, currently with $135.36 billion in INSM stock with ownership which is approximately 5.1238%.
